Table 3.
Effect of therapies on Functional Independence Measure scale
| ULC therapy | RFVE therapy | ||||||
|---|---|---|---|---|---|---|---|
| |
|
n |
Before |
After |
n |
Before |
After |
| Overall |
|
113 |
95.0 ± 21.4 |
101.9 ± 19.1* |
263 |
103.2 ± 20.7 |
110.8 ± 16.4* |
| Motor impairment |
F-M UE score ≤ 20 |
19 |
84.2 ± 26.2 |
89.3 ± 24.2* |
35 |
92.8 ± 20.7 |
101.2 ± 17.9* |
| 21 ≤ F-M UE score ≤ 40 |
29 |
94.0 ± 15.5 |
102.0 ± 15.9* |
72 |
100.4 ± 24.0 |
108.0 ± 19.0* |
|
| F-M UE score > 40 |
65 |
98.5 ± 21.3 |
105.6 ± 17.3* |
156 |
106.9 ± 18.0 |
114.2 ± 13.5* |
|
| Stroke to Rehabilitation Interval | ≤ 3months |
32 |
88.2 ± 25.8 |
100.0 ± 22.6* |
68 |
95.9 ± 23.3 |
110.1 ± 16.5* |
| 3 < months < 12 |
57 |
95.6 ± 18.2 |
100.4 ± 16.3* |
113 |
101.7 ± 20.0† |
108.2 ± 17.2* |
|
| ≥ 12 months | 24 | 102.5 ± 20.2 | 108.3 ± 20.0 | 82 | 111.0 ± 16.8† | 114.8 ± 14.4* | |
Data are presented as mean ± SD. n number of patients ULC Upper Limb Conventional, RFVE Reinforced Feedback in Virtual Environment, F-M UE Fugl – Meyer Upper Extremity.
* p ≤ 0.05 within group analysis (Wilcoxon test).
† p ≤ 0.05 between group analysis (Mann–Whitney U test).